In this article the author sought to highlight the most remarkable findings concerning headache secondary to COVID-19, specifically focusing on epidemiology, characteristics, pathophysiology, and treatments.
EAN Congress 2025 relocated to HELSINKI due to UN summit (dates remain 21-24 June)
September 20, 2024
Due to unforeseen developments, the 11th Congress of the European Academy of Neurology has been relocated and will now be held in Helsinki on June 21-24, 2025.
EAN co-hosting G7 side-event in Ancona, Italy, on 8 October
September 13, 2024
Upcoming Joint Sessions at Partner Societies’ Congresses
August 26, 2024
Latest Posts
-
-
Breaking newsCOVID-19
Incidence and Predictors of Thrombotic Complications in 4742 Patients with COVID-19 or Other Acute Infectious Respiratory Diseases: A Propensity Score-Matched Study
December 7, 2021In this study the authors retrospectively studied 4742 patients with acute infectious respiratory disease (AIRD); 2579 were diagnosed to have COVID-19 and treated with heparin, whereas 2163 had other causes of AIRD. -
Breaking newsCOVID-19
Infection of Brain Pericytes Underlying Neuropathology of COVID-19 Patients
December 7, 2021In this article the authors used state-of-the-art multiplexed immunostaining of human brains and demonstrated that expression of the SARS-CoV-2 receptor ACE2 is restricted to a subset of neurovascular pericytes. -
Breaking newsCOVID-19
Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer’s Disease Patients by Integrated Bioinformatics
December 7, 2021In this article the authors aimed to explore the interaction between COVID-19 and Alzheimer's disease by integrating bioinformatics to find the biomarkers which lead to AD occurrence and development with COVID-19 and provide early intervention. -
Breaking newsCOVID-19
Impact of COVID-19 on ‘Living Well’ with Mild-to-Moderate Dementia in the Community: Findings from the IDEAL Cohort
December 7, 2021In this article the authors aimed to explore the impact of the pandemic on community-dwelling individuals with mild-to-moderate dementia and compare responses with pre-pandemic data. -
Breaking newsCOVID-19
Clinical features and cognitive sequelae in COVID-19: a retrospective study on N=152 patients
December 7, 2021This work aimed at exploring how post-infective cognitive status relates to clinical/treatment outcomes by controlling for premorbid/current risk factors for cognitive deficits. -
Breaking newsCOVID-19
Prevalence of depression, anxiety, and psychological distress in patients with epilepsy during COVID-19: A systematic review
December 7, 2021The purpose of this systematic review study was to investigate the epidemic effect of COVID-19 on increasing the prevalence of mental disorders such as depression, anxiety, and sleep disorders in people with epilepsy. -
Breaking newsCOVID-19
Increased COVID-19 Mortality in People With Previous Cerebrovascular Disease: A Population-Based Cohort Study
December 7, 2021The aim of the study was to determine the association between previous stroke and mortality after coronavirus disease 2019 (COVID-19) according to sex, age groups, and stroke subtypes. -
Breaking newsCOVID-19
SARS-CoV-2 involvement in central nervous system tissue damage
December 7, 2021This overview attempts to give a thorough insight into SARS-CoV-2 neurological infection and highlights the possible mechanisms leading to the neurological manifestations observed in infected patients. -
Breaking newsCOVID-19
Parkinson’s disease and COVID-19: a systematic review and meta-analysis
December 7, 2021The goal of this study is to update the pooled prevalence of COVID-19 infection in patients with Parkinson's disease. -
Breaking newsCOVID-19
Neuroradiologic Imaging of Neurologic and Neuro-Ophthalmic Complications of Coronavirus-19 Infection
December 7, 2021The objective of this study was to review the literature and provide a summary of COVID-19-related neurologic and neuro-ophthalmic complications. -
This review gathers information from 64 reports of de novo movement disorders developing after/during infection with SARS-CoV-2
-
Breaking newsCOVID-19
Episodic long-term memory in post-infectious SARS-CoV-2 patients
December 7, 2021This study aimed at (1) assessing LTM functioning in post-infectious SARS-CoV-2 patients by accounting for premorbid and disease-related confounders and (2) exploring its cognitive etiology. -
Breaking newsCOVID-19
Varicella zoster virus-induced neurological disease after COVID-19 vaccination: a retrospective monocentric study
December 7, 2021In this study, the authors retrospectively evaluated patients admitted to their clinic and diagnosed with VZV-ND during the COVID-19 vaccination campaign (January–April 2021) and in the same months in the previous two years. -
Breaking newsCOVID-19
The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience
December 7, 2021CogEx is an international, multicentre MS dual-intervention (cognitive rehabilitation, aerobic exercise) randomized, controlled rehabilitation trial confined to people with progressive disease.